Thanks to medical advancements, heart attack deaths have dropped nearly 90% in the last 50 years. But deaths from these ...

In this high-yield, clinically focused session, Dr. Steven L. Cohn, one of the leading experts in perioperative medicine, ...

Decreases seen in mortality for acute MI, ischemic heart disease, while increases seen for mortality from other heart disease subtypes ...

If istaroxime is approved in the US for acute heart failure, this patent would provide protection to 2039 ...

Treat it like tobacco: avoid criminalizing it, discourage its use, and protect bystanders, says editorial. Cannabis use is ...

From 1970 to 2022, there was a decrease in heart disease mortality overall, but an increase in mortality from other heart ...

The Medical Center at Caverna, The Medical Center at Franklin and The Medical Center at Scottsville have all earned The Joint Commission’s Gold Seal of Approval for Acute Heart Attack Ready ...

In 1970, ischemic heart disease—mostly heart attacks—accounted for 91% of heart-related deaths. Today, that number has fallen ...

Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with AMI.

Risk factors include age, family history, heart disease, and being overweight. The symptoms of acute and chronic kidney disease can overlap but often differ in timing. People with AKI may notice a ...

Another major difference between acute and chronic kidney disease is how doctors monitor and measure them. In AKI, doctors ...